KARAM WEHBEH: Open Payments
NPI 1306356365 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,007 in 116 payments from 18 companies in 2025. Trend: 2023 $1,647 · 2024 $1,797 · 2025 $2,007
Food & beverage: $1,988Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $357 |
| ABBVIE INC. | 21 | $238 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $221 |
| Novo Nordisk Inc | 12 | $195 |
| PFIZER INC. | 9 | $173 |
| Amgen Inc. | 9 | $141 |
| Lilly USA, LLC | 7 | $105 |
| Astellas Pharma US Inc | 5 | $105 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $81 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
Products named: BREZTRI, Kerendia, VRAYLAR, OTEZLA, JARDIANCE, PREVNAR 20, Veozah, FARXIGA.
Industry payments across NJ — which companies pay providers there.
